Stay updated on Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 is displayed, and the earlier notices about government funding, operating status, and related updates have been removed.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a general notice about the government funding lapse and the NIH Clinical Center’s operating status, with links to opm.gov and cc.nih.gov. Updated the site to version 3.4.1, replacing 3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary toggle (Show glossary) and updated metadata labels for QC criteria and FEAR Act data (capitalization/phrasing changes). Revision updated to v3.4.0 (replacing v3.3.4).SummaryDifference0.2%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4; no other visible changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision 'v3.3.3' was added, and the 'HHS Vulnerability Disclosure' link and the previous revision 'v3.3.2' were removed.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page footer shows a revision update from v3.3.1 to v3.3.2, which appears to be an internal versioning change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page.